Galdu-irabazien kontua
KEWAUNEE SCIENTIFIC CORP /DE/
KEQU
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Apr 30, 2025 2025 FY | Apr 30, 2024 2024 FY | Apr 30, 2023 2023 FY | Apr 30, 2022 2022 FY | Apr 30, 2021 2021 FY | Apr 30, 2020 2020 FY | Apr 30, 2019 2019 FY | Apr 30, 2018 2018 FY | Apr 30, 2017 2017 FY | Apr 30, 2016 2016 FY | Apr 30, 2015 2015 FY | Apr 30, 2014 2014 FY | Apr 30, 2013 2013 FY | Apr 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
240.47 | 203.76 | 219.49 | 168.87 | 147.47 | 147.54 | 146.55 | 158.05 | 138.56 | 128.63 | 118.83 | 111.17 | 117.12 | 102.85 |
|
Diru-sarreren kostua
|
171.62 | 151.70 | 183.91 | 144.65 | 123.48 | 124.11 | 121.23 | 126.03 | - | - | - | - | - | - |
|
Irabazi gordina
|
68.86 | 52.05 | 35.59 | 24.22 | 23.99 | 23.43 | 25.32 | 32.02 | 26.61 | 23.71 | 21.77 | 22.03 | 22.26 | 19.16 |
|
Ustiapen-gastuak
|
51.10 | 33.77 | 30.22 | 26.83 | 25.31 | 25.77 | 23.21 | 22.93 | 20.07 | 18.01 | 16.54 | 16.07 | 16.98 | 16.44 |
|
Ikerketa eta garapena
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
17.76 | 18.28 | 5.36 | -2.61 | -1.32 | -2.35 | 2.11 | 9.09 | 6.54 | 5.70 | 5.23 | 5.96 | 5.28 | 2.71 |
|
Ez-ustiapeneko diru-sarrerak
|
2.97 | 5.16 | 0.87 | -0.12 | 1.30 | 3.62 | 8.32 | -1.65 | -1.68 | -1.77 | -0.58 | -1.42 | -1.63 | 0.17 |
|
Interesen diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interesen gastuak
|
0.49 | 1.80 | 1.73 | 0.63 | 0.39 | 0.49 | 0.37 | 0.30 | 0.29 | 0.31 | 0.33 | 0.37 | 0.36 | 0.45 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | - | - | - | - | 0.30 | - | - | - | - | - | - | - |
|
Zerga aurreko irabazia
|
19.92 | 15.05 | 7.38 | 3.59 | 3.18 | 1.92 | 4.97 | 10.73 | 8.22 | 7.47 | 5.81 | 7.39 | 6.91 | 2.54 |
|
Zerga-gastua
|
3.38 | -5.63 | 3.76 | 3.64 | 1.06 | -1.28 | -7.74 | 5.54 | 3.71 | 3.67 | 2.28 | 3.49 | 3.86 | 1.51 |
|
Partaidetza ez-kontrolatzailea
|
0.18 | 0.30 | 0.62 | 0.12 | 0.07 | 0.06 | 0.16 | 0.18 | 0.11 | 0.08 | 0.11 | 0.11 | 0.64 | 0.77 |
|
Irabazi garbia
|
11.41 | 18.75 | 0.74 | -6.13 | -3.67 | -4.69 | 1.53 | 5.19 | 4.52 | 3.80 | 3.53 | 3.90 | 3.04 | 1.03 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Apr 30, 2025 2025 FY | Apr 30, 2024 2024 FY | Apr 30, 2023 2023 FY | Apr 30, 2022 2022 FY | Apr 30, 2021 2021 FY | Apr 30, 2020 2020 FY | Apr 30, 2019 2019 FY | Apr 30, 2018 2018 FY | Apr 30, 2017 2017 FY | Apr 30, 2016 2016 FY | Apr 30, 2015 2015 FY | Apr 30, 2014 2014 FY | Apr 30, 2013 2013 FY | Apr 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
22.52 | 18.28 | 5.36 | -2.61 | -1.32 | -2.35 | 2.11 | 9.09 | 6.54 | 5.70 | 5.23 | 5.96 | 5.28 | 2.71 |
|
Akzioko irabazia (oinarrizkoa)
|
3.98 | 6.51 | 0.26 | -2.20 | -1.33 | -1.70 | 0.56 | 1.91 | 1.67 | 1.43 | 1.34 | 1.49 | 1.18 | 0.40 |
|
EPS diluitua
|
3.83 | 6.38 | 0.25 | -2.20 | -1.33 | -1.70 | 0.55 | 1.87 | 1.66 | 1.42 | 1.33 | 1.48 | 1.17 | 0.40 |
|
Akzioen batez besteko haztatua
|
2.86 | 2.88 | 2.82 | 2.79 | 2.76 | 2.75 | 2.74 | 2.72 | 2.71 | 2.67 | 2.63 | 2.61 | 2.59 | 2.58 |
|
Akzioen batez besteko haztatu diluitua
|
2.98 | 2.94 | 2.90 | 2.79 | 2.76 | 2.75 | 2.79 | 2.78 | 2.73 | 2.69 | 2.66 | 2.63 | 2.60 | 2.58 |
|
Irabazi globala
|
10.98 | 18.81 | 1.04 | -6.29 | 2.35 | -7.88 | 1.02 | 5.61 | 5.82 | 4.06 | 1.92 | 4.95 | 2.89 | -1.22 |